Non-Hodgkin lymphoma survival statistics

Improvement

Change in non-Hodgkin lymphoma 10-year survival between the 1970s and 2010s, UK

 

As with most cancers, survival for NHL (all subtypes combined) is improving. Some of the increase is likely to be attributable to changes in the diagnosis, classification and registration of NHL, so interpretation of these trends should be undertaken with caution.

One-year age-standardised Open a glossary item net survival for NHL in men has increased from 49% during 1971-1972 to 80% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 30 percentage points.[1] In women, one-year survival has increased from 50% to 79% over the same time period (a difference of 30 percentage points). 

Non-Hodgkin Lymphoma (C82-C85), Age-Standardised One-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five- and ten-year survival has increased by an even greater amount than one-year survival since the early 1970s. Five-year age-standardised net survival for NHL in men has increased from 30% during 1971-1972 to a predicted survival of 68% during 2010-2011 in England and Wales – an absolute survival difference of 39 percentage points.[1] In women, five-year survival has increased from 31% to 70% over the same time period (a difference of 39 percentage points).

Non-Hodgkin Lymphoma (C82-C85), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year age-standardised net survival for NHL in men has increased from 22% during 1971-1972 to a predicted survival of 62% during 2010-2011 in England and Wales – an absolute survival difference of 41 percentage points.[1] In women, ten-year survival has increased from 22% to 64% over the same time period (a difference of 42 percentage points). Overall, more than 6 in 10 people diagnosed with NHL today are predicted to survive their disease for at least ten years.

Non-Hodgkin Lymphoma (C82-C85), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

See also

Non-Hodgkin lymphoma incidence trends over time

Non-Hodgkin lymphoma mortality trends over time

Cancer survival statistics for common cancers in the UK

Hodgkin lymphoma survival statistics

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.

About this data

Data is for: England and Wales, 1971-2011, ICD-10 C82-C85

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Cancer stats explained

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate Online 

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.